J8610 HCPCS Level II code: Methotrexate; oral, 2.5 mg
J8610 is the HCPCS code for “Methotrexate; oral, 2.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8610Methotrexate; oral, 2.5 mg
Short description: Methotrexate oral 2.5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J8610 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1995
Where J8610 sits
- 1J codesDrugs administered other than orally
- 2Active code J8610Methotrexate; oral, 2.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8610 mean?
J8610 is the HCPCS code for “Methotrexate; oral, 2.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8610?
CMS lists J8610’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8610
All J codesJ8541Dexamethasone (hemady), oral, 0.25 mgJ8560Etoposide; oral, 50 mgJ8562Fludarabine phosphate, oral, 10 mgJ8565Gefitinib, oral, 250 mgJ8597Antiemetic drug, oral, not otherwise specifiedJ8600Melphalan; oral, 2 mgJ8611Methotrexate (jylamvo), oral, 2.5 mgJ8612Methotrexate (xatmep), oral, 2.5 mgJ8650Nabilone, oral, 1 mgJ8655Netupitant 300 mg and palonosetron 0.5 mg, oralJ8670Rolapitant, oral, 1 mgJ8700Temozolomide, oral, 5 mg